Showing results (91-100 of 327) with videos related to
Sort By:
Pageof 33
Developmental Biology|May 13, 1998
Specific arrest of cardiogenesis in cultured embryonic stem cells lacking Cripto-1C Xu, G Liguori, E D Adamson, et al.American Journal of Obstetrics and Gynecology|March 1, 1980
The effect of pregnancy on suspected pituitary adenomas after conservative management of ovulation defects associated with galactorrheaA B Shewchuk, G D Adamson, P Lessard, et al.Development (Cambridge, England)|January 7, 1999
Abrogation of the Cripto gene in mouse leads to failure of postgastrulation morphogenesis and lack of differentiation of cardiomyocytesC Xu, G Liguori, M G Persico, et al.The Journal of Physical Chemistry. A|November 13, 2018
Detection of Aliphatically Bridged Multi-Core Polycyclic Aromatic Hydrocarbons in Sooting Flames with Atmospheric-Sampling High-Resolution Tandem Mass SpectrometryB D Adamson, S A Skeen, M Ahmed, et al.Differentiation; Research in Biological Diversity|January 1, 1987
Proteoglycan-19, laminin and collagen type IV production is correlated with the levels of mRNA in F9 cell aggregates differentiating in the presence or absence of cyclic AMPA Grover, S A Edwards, M Bourdon, et al.Revue Scientifique Et Technique (International Office of Epizootics)|October 13, 2020
Preparing for animal health emergencies: considerations for economic evaluationD Adamson, W Gilbert, K Hamilton, et al.Molecular Cell|July 1, 2004
Coactivating factors p300 and CBP are transcriptionally crossregulated by Egr1 in prostate cells, leading to divergent responsesJianxiu Yu, Ian de Belle, Hongyan Liang, et al.The Journal of Biological Chemistry|December 8, 2004
Vinculin controls PTEN protein level by maintaining the interaction of the adherens junction protein beta-catenin with the scaffolding protein MAGI-2M Cecilia Subauste, Perihan Nalbant, Eileen D Adamson, et al.The Journal of Cell Biology|April 1, 1996
UV activates growth factor receptors via reactive oxygen intermediatesR P Huang, J X Wu, Y Fan, et al.Cancer Gene Therapy|September 3, 2005
The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectinV Baron, E D Adamson, A Calogero, et al.Pageof 33